BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 31598912)

  • 1. Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study.
    Di Iorio BR; Bellasi A; Raphael KL; Santoro D; Aucella F; Garofano L; Ceccarelli M; Di Lullo L; Capolongo G; Di Iorio M; Guastaferro P; Capasso G;
    J Nephrol; 2019 Dec; 32(6):989-1001. PubMed ID: 31598912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium citrate versus sodium bicarbonate for metabolic acidosis in patients with chronic kidney disease: A randomized controlled trial.
    Sorohan BM; Obrișcă B; Jurubiță R; Lupușoru G; Achim C; Andronesi A; Frățilă G; Berechet A; Micu G; Ismail G
    Medicine (Baltimore); 2024 Mar; 103(10):e37475. PubMed ID: 38457574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium bicarbonate for kidney transplant recipients with metabolic acidosis in Switzerland: a multicentre, randomised, single-blind, placebo-controlled, phase 3 trial.
    Mohebbi N; Ritter A; Wiegand A; Graf N; Dahdal S; Sidler D; Arampatzis S; Hadaya K; Mueller TF; Wagner CA; Wüthrich RP
    Lancet; 2023 Feb; 401(10376):557-567. PubMed ID: 36708734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oral sodium bicarbonate supplementation on progression of chronic kidney disease in patients with chronic metabolic acidosis: study protocol for a randomized controlled trial (SoBic-Study).
    Gaggl M; Cejka D; Plischke M; Heinze G; Fraunschiel M; Schmidt A; Hörl WH; Sunder-Plassmann G
    Trials; 2013 Jul; 14():196. PubMed ID: 23826760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Serum Bicarbonate Levels on Muscle Mass and Kidney Function in Pre-Dialysis Chronic Kidney Disease Patients.
    Kittiskulnam P; Srijaruneruang S; Chulakadabba A; Thokanit NS; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
    Am J Nephrol; 2020; 51(1):24-34. PubMed ID: 31752000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction of metabolic acidosis improves insulin resistance in chronic kidney disease.
    Bellasi A; Di Micco L; Santoro D; Marzocco S; De Simone E; Cozzolino M; Di Lullo L; Guastaferro P; Di Iorio B;
    BMC Nephrol; 2016 Oct; 17(1):158. PubMed ID: 27770799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does oral sodium bicarbonate therapy improve function and quality of life in older patients with chronic kidney disease and low-grade acidosis (the BiCARB trial)? Study protocol for a randomized controlled trial.
    Witham MD; Band MM; Littleford RC; Avenell A; Soiza RL; McMurdo ME; Sumukadas D; Ogston SA; Lamb EJ; Hampson G; McNamee P;
    Trials; 2015 Aug; 16():326. PubMed ID: 26231610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Treatment of Metabolic Acidosis on Vascular Endothelial Function in Patients with CKD: A Pilot Randomized Cross-Over Study.
    Kendrick J; Shah P; Andrews E; You Z; Nowak K; Pasch A; Chonchol M
    Clin J Am Soc Nephrol; 2018 Oct; 13(10):1463-1470. PubMed ID: 30237219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful correction of metabolic acidosis is difficult to achieve in chronic kidney disease.
    Caravaca-Fontán F; Díaz-Campillejo R; Valladares J; López Arnaldo C; Barroso S; Luna E; Caravaca F
    Nefrologia (Engl Ed); 2020; 40(3):328-335. PubMed ID: 31862183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective, multicenter, randomized, controlled study: the correction of metabolic acidosis with use of bicarbonate in Chronic Renal Insufficiency (UBI) Study.
    Di Iorio B; Aucella F; Conte G; Cupisti A; Santoro D
    J Nephrol; 2012; 25(3):437-40. PubMed ID: 21928233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Sodium Bicarbonate in CKD Stages 3 and 4: A Randomized, Placebo-Controlled, Multicenter Clinical Trial.
    Melamed ML; Horwitz EJ; Dobre MA; Abramowitz MK; Zhang L; Lo Y; Mitch WE; Hostetter TH
    Am J Kidney Dis; 2020 Feb; 75(2):225-234. PubMed ID: 31699517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, Controlled Trial of TRC101 to Increase Serum Bicarbonate in Patients with CKD.
    Bushinsky DA; Hostetter T; Klaerner G; Stasiv Y; Lockey C; McNulty S; Lee A; Parsell D; Mathur V; Li E; Buysse J; Alpern R
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):26-35. PubMed ID: 29102959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic acidosis is associated with increased risk of adverse kidney outcomes and mortality in patients with non-dialysis dependent chronic kidney disease: an observational cohort study.
    Tangri N; Reaven NL; Funk SE; Ferguson TW; Collister D; Mathur V
    BMC Nephrol; 2021 May; 22(1):185. PubMed ID: 34011303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial.
    Wesson DE; Mathur V; Tangri N; Stasiv Y; Parsell D; Li E; Klaerner G; Bushinsky DA
    Lancet; 2019 Apr; 393(10179):1417-1427. PubMed ID: 30857647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance to Sodium in Patients With CKD-Induced Metabolic Acidosis: Does the Accompanying Anion Matter?
    Bushinsky DA
    Am J Kidney Dis; 2019 Jun; 73(6):858-865. PubMed ID: 30518477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and population of the VALOR-CKD study: a multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of veverimer in slowing progression of chronic kidney disease in patients with metabolic acidosis.
    Mathur VS; Bushinsky DA; Inker L; Klaerner G; Li E; Parsell D; Perkovic V; Stasiv Y; Walker M; Wesson DE; Wheeler DC; Tangri N
    Nephrol Dial Transplant; 2023 May; 38(6):1448-1458. PubMed ID: 36331426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction of metabolic acidosis improves muscle mass and renal function in chronic kidney disease stages 3 and 4: a randomized controlled trial.
    Dubey AK; Sahoo J; Vairappan B; Haridasan S; Parameswaran S; Priyamvada PS
    Nephrol Dial Transplant; 2020 Jan; 35(1):121-129. PubMed ID: 30053298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic acidosis is common and associates with disease progression in children with chronic kidney disease.
    Harambat J; Kunzmann K; Azukaitis K; Bayazit AK; Canpolat N; Doyon A; Duzova A; Niemirska A; Sözeri B; Thurn-Valsassina D; Anarat A; Bessenay L; Candan C; Peco-Antic A; Yilmaz A; Tschumi S; Testa S; Jankauskiene A; Erdogan H; Rosales A; Alpay H; Lugani F; Arbeiter K; Mencarelli F; Kiyak A; Dönmez O; Drozdz D; Melk A; Querfeld U; Schaefer F;
    Kidney Int; 2017 Dec; 92(6):1507-1514. PubMed ID: 28729033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approach to the Treatment of Chronic Metabolic Acidosis in CKD.
    Raphael KL
    Am J Kidney Dis; 2016 Apr; 67(4):696-702. PubMed ID: 26776539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fruit and Vegetable Treatment of Chronic Kidney Disease-Related Metabolic Acidosis Reduces Cardiovascular Risk Better than Sodium Bicarbonate.
    Goraya N; Munoz-Maldonado Y; Simoni J; Wesson DE
    Am J Nephrol; 2019; 49(6):438-448. PubMed ID: 30995657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.